2015 Meetings

December 2015 Meetings:

AGAR November 2015 Executive Minutes (PDF)
AGAR November 2015 Executive Agenda (PDF)
2. AGAR July 2015 Executive Minutes (PDF)
4.1 Retirement Linda Joyce(PDF)
4.2 Nascar Survey Request (PDF)
4.3 Australian AMR Data Request for Global Resistance Maps (PDF)
4.4 AGAR Labs Tony Korman (PDF)
6. AGAR Operating Procedures (PDF)
7.1 June 2015 Financial Report (PDF)
7.2 2014 2015 Financial Report (PDF)
7.3 September 2015 Financial Report(PDF)
8.1 AGAR 2012 2013 Final Budget (PDF)
8.2 AGAR 2013 2014 Updated Budget (PDF)
8.3 AGAR 2014 2015 Updated Budget (PDF)
9.1 2015 2016 Proposed Budget (PDF)
9.2 ACSQHC Funding Letter (PDF)
11.1 Antimicrobial Resistance Surveillance Applications (PDF)
11.2 Due Diligence Web Capture for AGAR (PDF)
12.1 Financial Report (PDF)
18.1 ST1193 and ST131 Genomics Study (PDF)
18.2 Population and Structure of Invasive E. coli and Kp in Australia (PDF)
18.3 E. coli Kp CTX MIC >1 ang Gen >8 AGAR isolates (PDF)
20.1 AMR Strategy (PDF)
21. National Antimicrobial Resistance Genomics Initiative (PDF)

July 2015 Meetings:

July 2015 Executive Agenda (PDF)
AGAR Executive Meeting Minutes July 2015 (PDF)
5.3 Kathy Meleady ACSQHC AGAR Data (PDF)
5.5 Old AGAR Data Alison Vickery (PDF)
10.2.1.3. Williamson (PDF)
5.6 Doherty Centre Invitation (PDF)
5.7 Julie Toms Office of Health Protection (PDF)
5.8 Australia’s AMR Strategy (PDF)
5.9 Rob Peterson Retirement (PDF)
5.10 GNSOP 2015 RPAH (PDF)
5.11 Liz Temkin AMR Surveillance Data (PDF)
5.12 Sumantha Gandra AMR Surveillance Data (PDF)
5.12.1 Data Requested (PDF)
5.12.2 Data Submitted (PDF)
5.13 Penny Williams Meda Pharmaceuticals Australia (PDF)
5.14 Jonathon Brett RPAH (PDF)
5.15 Kathy Meleady Data Storage Arrangements (PDF)
5.16 John Turnidge NAUSP AGAR Data (PDF)
6.1 December 2014 Financial Report (PDF)
6.2 March 2015 Financial Report (PDF)
6.3 June 2015 Financial Report (PDF)
6.4 2014 2015 Financial Report (PDF)
7.1 AGAR 2012 2013 Final Budget (PDF)
7.2 AGAR 2013 2014 Updated Budget (PDF)
7.3 AGAR 2014 2015 Updated Budget (PDF)
8. 2015 2016 AGAR Budget (PDF)
14.1 AESOP 2014 CDI Manuscript (PDF)
15.1 ASSOP 2014 CDI Manuscript (PDF)
16.1 EnSOP CDI Manuscript (PDF)
21. AGAR Operating Procedures (PDF)
22.1 AGAR and HHA Proposed Collaboration (PDF)
22.2 AMR Surveillance Application (PDF)
22.3 Extension of Pilot Study (PDF)
26.1 Darren Trott (PDF)
26.2 Jon Iredell (PDF)
26.3 Norelle Sherry (PDF)
26.4 Alex O’Neill (PDF)

Copyright © 2004-2022 Australian Group on Antimicrobial Resistance (AGAR). Last Updated December 2017.